查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1784835

全球玻璃化市場

Vitrification
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球玻璃化冷凍市場規模將達到 221 億美元

全球玻璃化冷凍市場規模預計在2024年為92億美元，預計到2030年將達到221億美元，在分析期內（2024-2030年）的複合年成長率為15.7%。卵子是本報告分析的細分市場之一，預計其複合年成長率為16.5%，到分析期結束時規模將達到125億美元。而設備細分市場在分析期間內的複合年成長率預計為14.0%。

美國市場預計將達到 25 億美元，中國市場複合年成長率將達到 20.9%

美國玻璃化市場規模預計在2024年達到25億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到48億美元，在2024-2030年的分析期間內，複合年成長率為20.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為11.5%和14.1%。在歐洲，預計德國市場的複合年成長率約為12.5%。

全球玻璃化市場－主要趨勢與促進因素摘要

為什麼玻璃化冷凍技術會成為冷凍保存技術的突破？

玻璃化冷凍技術徹底改變了冷凍保存領域，為保存胚胎、卵子、幹細胞和組織等生物樣本提供了一種高效的方法。與傳統的慢速冷凍技術不同，玻璃化冷凍技術可將生物材料快速冷卻至玻璃狀，而不會形成破壞細胞結構的冰晶。這種先進的冷凍保存方法已廣泛應用於輔助生殖技術 (ART)，尤其是在體外受精 (IVF) 診所，用於保存胚胎和卵子，且存活率顯著提高。由於生育能力延遲、影響生育能力的治療以及生殖醫學的進步等因素，對生育力保存的需求不斷增加，從而推動了 ART 治療中對玻璃化冷凍的需求。此外，玻璃化冷凍技術在再生醫學、生物銀行和器官移植研究中發揮重要作用，在這些研究中，長期保存可行的生物材料對於未來的醫學突破至關重要。隨著對低溫生物學的科學認知的不斷進步，玻璃化冷凍有望成為多種醫療和研究應用中冷凍保存的黃金標準。

科技進步如何改進玻璃化技術？

冷凍保存技術的不斷創新顯著提高了玻璃化冷凍的效率、細胞活力和保存能力。超快速冷卻技術和先進冷凍保護劑溶液的開發提高了解凍後的存活率，同時最大限度地降低了細胞損傷的風險。自動化玻璃化冷凍系統也已投入使用，減少了人為錯誤，並使生育診所和實驗室的冷凍程序標準化。此外，冷凍保存系統的改進，例如封閉式玻璃化冷凍裝置，解決了污染問題，並確保了保存的生物樣本的無菌性和長期安全性。奈米技術也在玻璃化冷凍研究中發揮新興的作用，科學家正在探索奈米增強冷凍保護劑，以進一步提高細胞在冷凍和解凍過程中的完整性。此外，基於人工智慧的冷凍保存通訊協定最佳化使研究人員和臨床醫生能夠根據個體生物學特徵客製化冷凍條件，從而改善玻璃化冷凍效果。這些技術進步不僅提高了玻璃化冷凍的可靠性，還為其在再生醫學、基因保存和器官移植研究中的應用開啟了新的可能性。

阻礙採用玻璃化冷凍保存技術的挑戰有哪些？

儘管玻璃化冷凍比傳統冷凍方法效率更高，但它仍面臨若干挑戰，影響其在臨床和研究環境中的廣泛應用。一個主要障礙是玻璃化冷凍設備、專用冷凍保護劑和冷凍保存設施的高成本，限制了它們在資源匱乏的醫療環境中的普及。此外，該技術需要高水準的專業知識和精確度，需要對胚胎學家、生物學家和實驗室技術人員進行大量培訓才能獲得一致的結果。另一個挑戰在於圍繞人類胚胎和生殖細胞長期儲存的倫理和法律考量。此外，對長期儲存後玻璃化細胞的遺傳和結構完整性的擔憂是一個持續的研究領域。應對這些挑戰需要不斷改進具有成本效益的冷凍保存方法、標準化的訓練通訊協定，並對玻璃化生物樣本的長期活力進行更全面的研究。

哪些因素推動了玻璃化市場的成長？

玻璃化冷凍市場的成長受到多種因素的推動，包括不孕症治療需求的不斷成長、再生醫學的進步以及生物樣本庫和基因研究的擴展。全球不孕症盛行率的上升和體外受精（IVF）治療的日益普及，大大促進了玻璃化冷凍技術在生殖醫學中的應用。此外，幹細胞治療和器官保存研究的擴展，也推動了對可靠的冷凍保存方法的需求，這些方法能夠保持細胞活力，以備未來的醫療應用。個人化醫療和基因保存解決方案的不斷發展，進一步激發了人們對玻璃化冷凍作為保存生物多樣性和稀有遺傳物質關鍵工具的興趣。冷凍保護劑、自動化和人工智慧驅動的冷凍最佳化技術的持續創新，正在推動玻璃化冷凍市場的顯著成長，塑造生殖醫學、生物醫學研究和長期生物保存的未來。

部分

檢體（卵子、裝置、精子）；最終用途（IVF診所、生物庫）

受訪公司範例

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies SA
  • KITAZATO CORPORATION

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP33309

Global Vitrification Market to Reach US$22.1 Billion by 2030

The global market for Vitrification estimated at US$9.2 Billion in the year 2024, is expected to reach US$22.1 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Oocytes, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 20.9% CAGR

The Vitrification market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Vitrification Market - Key Trends & Drivers Summarized

Why Is Vitrification Emerging as a Breakthrough in Cryopreservation?

Vitrification has revolutionized the field of cryopreservation, offering a highly efficient method for preserving biological specimens such as embryos, oocytes, stem cells, and tissues. Unlike traditional slow-freezing techniques, vitrification rapidly cools biological materials to a glass-like state without forming ice crystals, which can damage cellular structures. This advanced cryopreservation method has gained widespread adoption in assisted reproductive technology (ART), particularly in in-vitro fertilization (IVF) clinics, where it is used to preserve embryos and eggs with significantly higher survival rates. The increasing demand for fertility preservation, driven by delayed parenthood trends, medical treatments affecting fertility, and advancements in reproductive medicine, has fueled the need for vitrification in ART procedures. Additionally, vitrification is playing a crucial role in regenerative medicine, biobanking, and organ transplantation research, where the long-term storage of viable biological materials is essential for future medical breakthroughs. As scientific understanding of cryobiology continues to advance, vitrification is expected to become the gold standard for cryopreservation across multiple medical and research applications.

How Are Technological Advancements Improving Vitrification Techniques?

Continuous innovations in cryopreservation technology have led to significant improvements in vitrification efficiency, survival rates, and storage capabilities. The development of ultra-rapid cooling techniques and advanced cryoprotectant solutions has minimized the risks of cellular damage while enhancing post-thaw viability. Automated vitrification systems have also been introduced, reducing human error and standardizing freezing procedures in fertility clinics and research laboratories. Additionally, improvements in cryo-storage systems, such as closed-system vitrification devices, have addressed contamination concerns, ensuring the sterility and long-term safety of stored biological samples. Nanotechnology is also playing an emerging role in vitrification research, with scientists exploring nano-enhanced cryoprotectants that further improve cell integrity during freezing and thawing. Moreover, AI-driven optimization of cryopreservation protocols is enhancing vitrification outcomes, allowing researchers and clinicians to customize freezing conditions based on individual biological characteristics. These technological advancements are not only improving the reliability of vitrification but also expanding its potential applications in regenerative medicine, genetic preservation, and organ transplantation research.

What Challenges Are Hindering the Adoption of Vitrification in Cryopreservation?

Despite its superior efficiency compared to traditional freezing methods, vitrification faces several challenges that impact its widespread implementation in medical and research settings. One of the primary obstacles is the high cost associated with vitrification equipment, specialized cryoprotectants, and cryo-storage facilities, making it less accessible in low-resource healthcare environments. Additionally, the technique requires a high level of expertise and precision, necessitating extensive training for embryologists, biologists, and laboratory technicians to achieve consistent results. Another challenge lies in the ethical and legal considerations surrounding the long-term storage of human embryos and reproductive cells, as different countries have varying regulations governing cryopreservation practices. Furthermore, concerns regarding the potential genetic and structural integrity of vitrified cells over extended storage periods remain an area of ongoing research. Addressing these challenges will require continued advancements in cost-effective cryopreservation methods, standardized training protocols, and more comprehensive studies on the long-term viability of vitrified biological specimens.

What Factors Are Driving the Growth of the Vitrification Market?

The growth in the vitrification market is driven by several factors, including the increasing demand for fertility preservation, advancements in regenerative medicine, and the expansion of biobanking and genetic research. The rising global prevalence of infertility and the growing acceptance of IVF treatments have significantly contributed to the adoption of vitrification in reproductive medicine. Additionally, the expansion of stem cell therapies and organ preservation research has increased the demand for reliable cryopreservation methods that maintain cellular viability for future medical applications. The ongoing development of personalized medicine and genetic storage solutions has further fueled interest in vitrification as a critical tool for preserving biological diversity and rare genetic materials. With continuous innovations in cryoprotectants, automation, and AI-driven cryo-optimization, the vitrification market is poised for substantial growth, shaping the future of reproductive health, biomedical research, and long-term biological preservation.

SCOPE OF STUDY:

The report analyzes the Vitrification market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Specimen (Oocytes, Devices, Sperm); End-Use (IVF Clinics, Biobanks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies S.A.
  • KITAZATO CORPORATION

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vitrification - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Accelerating Demand for Fertility Preservation Solutions Drives Adoption of Vitrification Technologies
    • Breakthroughs in Cryobiology Research Strengthen the Scientific Case for Vitrification Over Slow Freezing
    • Rising IVF Success Rates Through Vitrification Expands Addressable Market in Assisted Reproductive Technologies
    • Increasing Oncology Cases and Fertility Preservation Among Cancer Patients Spurs Growth in Medical Applications
    • Growing Demand for Oocyte and Embryo Banking Throws the Spotlight on Vitrification as the Preferred Cryopreservation Method
    • Technological Advancements in Cryoprotectants and Warming Protocols Enhance Viability and Post-Thaw Survival
    • Regulatory Approvals and Guidelines for Embryo and Gamete Storage Boost Clinical Adoption of Vitrification
    • Expansion of Egg Donation and Surrogacy Programs Generates Accelerated Demand for Vitrification-Based Cryostorage
    • Rising Global Awareness of Fertility Options Among Women in Career-Oriented Demographics Drives Uptake
    • Increased Usage of Vitrification in Livestock Embryo Preservation Propels Agricultural and Veterinary Applications
    • Integration of Vitrification with Time-Lapse Imaging and AI-Driven Embryo Selection Optimizes IVF Outcomes
    • Surge in Cross-Border Reproductive Care Expands Global Demand for Safe and Efficient Cryostorage
    • Demand for Long-Term Cell and Tissue Preservation in Stem Cell and Regenerative Medicine Sustains Market Growth
    • Emergence of Portable Vitrification Devices Spurs Decentralized Cryopreservation Capabilities in Remote Clinics
    • Growth of Fertility Tech Startups and Cryobank Infrastructure Strengthens Business Case for Market Investment
    • Collaborative Research on Cryopreservation of Organoids and 3D Cell Cultures Expands Therapeutic Use Cases
    • Adoption of Vitrification for Sperm Preservation in High-Performance Animal Breeding Opens New Revenue Streams
    • Ethical, Legal, and Storage Duration Considerations Create Challenges and Opportunities for Policy Innovation
    • Use of Vitrification in Preservation of Endangered Species Strengthens Conservation Biology Applications
    • Demand for Cost-Effective Cryopreservation Solutions in Emerging Markets Drives Technology Localization
    • Rising Investments in Cell Therapy Manufacturing Infrastructure Throws the Spotlight on Vitrification's Role in Biobanking
    • Public and Private Initiatives to Expand Reproductive Health Services Propel Adoption of Vitrification in Clinical Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vitrification Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Oocytes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Sperm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for IVF Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • JAPAN
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CHINA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • EUROPE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • FRANCE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • GERMANY
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • INDIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AFRICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030

IV. COMPETITION